<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:creativeCommons="http://backend.userland.com/creativeCommonsRssModule" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/" version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:media="http://search.yahoo.com/mrss/">
  <channel>
    <title>Nature Precedings - Tag feed for endothelial cells</title>
    <link>http://precedings.nature.com/tags/endothelial%20cells</link>
    <description>Recently posted documents tagged with 'endothelial cells'</description>
    <dc:publisher>Nature Publishing Group</dc:publisher>
    <dc:language>en</dc:language>
    <prism:publicationName>Nature Precedings</prism:publicationName>
    <image>
      <title>Nature Precedings</title>
      <url>http://precedings.nature.com/images/header_logo.gif</url>
      <link>http://precedings.nature.com</link>
    </image>
    <atom:link type="application/rss+xml" rel="self" href="http://precedings.nature.com/tags/endothelial%20cells/feed"/>
    <item>
      <title>Transforming growth factor-beta 1 (tgf-&amp;#946;1) induces angiogenesis through vascular endothelial growth factor (vegf)-mediated apoptosis</title>
      <link>http://dx.doi.org/10.1038/npre.2008.1758.1</link>
      <description>VEGF and TGF-&amp;#946;1 induce angiogenesis but have opposing effects on endothelial cells. VEGF protects endothelial cells from apoptosis; TGF-&amp;#946;1 induces apoptosis. We have previously shown that VEGF / VEGF receptor-2 (flk-1) signaling mediates TGF-&amp;#946;1 induction of apoptosis. This finding raised an important question: Does this mechanism stimulate or inhibit angiogenesis? Here we report that VEGF-mediated apoptosis is required for TGF-&amp;#946;1 induction of angiogenesis. In vitro the apoptotic effect of TGF-&amp;#946;1 on endothelial cells is rapid and followed by a long period in which the cells are refractory to apoptosis induction by TGF-&amp;#946;1. Inhibition of VEGF / flk-1 signaling abrogates formation of vessel-like structures by TGF-&amp;#946;1 with an effect comparable to that of z-VAD, an apoptosis inhibitor. Similarly, genetic deficiency of VEGF abolishes TGF-&amp;#946;1 upregulation of endothelial cell differentiation and formation of vascular structures in embryoid bodies. In vivo TGF-&amp;#946;1 induces endothelial cell apoptosis as rapidly as in vitro. Inhibition of VEGF blocks TGF-&amp;#946;1 induction of both apoptosis and angiogenesis, an effect similar to that of z-VAD. Thus, TGF-&amp;#946;1 induction of angiogenesis requires rapid and transient endothelial cell apoptosis mediated by VEGF/flk-1. This novel, unexpected role of VEGF and flk-1 indicates VEGF-mediated apoptosis as a potential target to control angiogenesis.</description>
      <guid>http://dx.doi.org/10.1038/npre.2008.1758.1</guid>
      <pubDate>Thu, 03 Apr 2008 20:16:15 UTC</pubDate>
      <dc:title>Transforming growth factor-beta 1 (tgf-&amp;#946;1) induces angiogenesis through vascular endothelial growth factor (vegf)-mediated apoptosis</dc:title>
      <dc:identifier>doi:10.1038/npre.2008.1758.1</dc:identifier>
      <dc:date>2008-04-03</dc:date>
      <dc:creator>Giovanni Ferrari</dc:creator>
      <prism:publicationName>Nature Precedings</prism:publicationName>
      <prism:publicationDate>2008-04-03T20:16:15Z</prism:publicationDate>
      <prism:category>Manuscript</prism:category>
      <prism:section>Cancer</prism:section>
      <media:thumbnail url="http://precedings.nature.com/documents/1758/version/1/files/npre20081758-1.pdf.thumb.png"/>
      <creativeCommons:license>http://creativecommons.org/licenses/by/3.0/</creativeCommons:license>
    </item>
  </channel>
</rss>
